FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement